Compare LGND & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGND | NATL |
|---|---|---|
| Founded | 1987 | 2023 |
| Country | United States | United States |
| Employees | 68 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.5B |
| IPO Year | N/A | 2023 |
| Metric | LGND | NATL |
|---|---|---|
| Price | $299.86 | $47.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | ★ $256.29 | $45.60 |
| AVG Volume (30 Days) | 354.1K | ★ 520.3K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.98 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $4,354,000,000.00 |
| Revenue This Year | $1.25 | $6.13 |
| Revenue Next Year | $19.41 | $4.24 |
| P/E Ratio | ★ $76.27 | $163.97 |
| Revenue Growth | N/A | ★ 0.86 |
| 52 Week Low | $131.67 | $26.59 |
| 52 Week High | $326.63 | $48.50 |
| Indicator | LGND | NATL |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 73.55 |
| Support Level | $290.20 | $43.51 |
| Resistance Level | $326.63 | $48.50 |
| Average True Range (ATR) | 10.96 | 0.63 |
| MACD | -3.74 | 0.24 |
| Stochastic Oscillator | 24.94 | 86.49 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
NCR Atleos Corp is a financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers, and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels, all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware, and its proprietary Allpoint network. Atleos manages its operations in the following segments: Self-Service Banking, which generates maximum revenue, Network, and Telecommunications and Technology. Geographically, it derives maximum revenue from the U.S.